Diabetes

Adults above 50 with Type 1 diabetes are nearly three times as likely to develop incident dementia as those without. Read more.

Metformin reduces the incidence of intermediate age-related macular degeneration by nearly 40% in people with Type 2 diabetes, a 2026 study has found.

Around 50% of patients with Type 2 diabetes have fatty pancreas disease, a substantial yet arguably overlooked metabolic burden.

Researchers reveal the anatomical sites where people with Type 2 diabetes experience a particularly higher risk of fracture.

Londoners are tuning to unsafe alternatives as NHS rollout of weight loss drugs stalls, according to a new report from the London Assembly Health Committee.

Patients with brain metastases and Type 2 diabetes taking GLP-1RAs had a significantly lower risk of mortality over 3 years compared with nonusers in a 2026 cohort study.

GLP-1RAs produce greater weight loss results among women than men, a 2026 systematic review and meta-analysis has found.

The FDA has issued warning letters to 30 telehealth companies for reportedly making false claims about GLP-1 products, amid a major crackdown on pharmaceutical advertisements.